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Organic and aqueous extracts obtained from 14 Kenyan medicinal plants were screened for their antimalarial properties on two strains of
Plasmodium falciparum (K1 chloroquine resistant and NF54 chloroquine sensitive). Dichloromethane extracts had the highest activities with
IC50 ranging from 1.4 to 35.2 μg/ml. These extracts together with methanol extract of Turraea robusta were tested for their cytotoxicity properties
in vitro on mammalian L6 cell line. The cytotoxicities ranged from N90 to 0.34 μg/ml. Selectivity index (IC50 L6 cells/IC50 P. falciparum) was
also determined. Vernonia lasiopus had the highest selectivity index (SI) of greater than 10 while Warbugia ugandensis had the lowest SI of 0.24.
This study suggests that V. lasiopus has a high potential for exploitation as a source of antimalarial agents.
© 2006 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Antiplasmodial; Medicinal plants; Plasmodium; Cytotoxicity1. Introduction
In spite of intensive efforts to control malaria, the disease
continues to be one of the greatest health problems facing
Africa. Although a number of advances have been made
towards understanding the disease, relatively few antimalarial
drugs have been developed in the last 30 years (Ridley, 2002).
Since the treatment and control of malaria depends largely on a
limited number of chemoprophylactic and chemotherapeutic
agents, there is an urgent need to develop novel, affordable
antimalarial treatments. This urgency has further been high-
lighted by the increasing prevalence of drug resistant strains of
malaria parasite Plasmodium falciparum, which contribute to
the increase of the disease burden. (Clarkson et al., 2004).
Traditional medicines have been used to treat malaria for
thousand of years and are a source of two main groups
(artemisinin and quinine derivatives) of modern antimalarial
drugs (Tagbota and Townson, 2001). Traditional medicine still
remains an important and sustainable source of treatment due to⁎ Corresponding author.
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0254-6299/$ - see front matter © 2006 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2006.11.004difficulties in poor areas in being able to afford and access
effective antimalarial drugs. (Willox and Bodeker, 2004;
Tagbota and Townson, 2001). It is estimated that in Africa, up
to 80% of the population uses traditional medicine for primary
health care. Provision of safe and effective traditional medicine
therapies could become a critical tool to increase access to
health care (WHO, 2003). Use of ‘untested’ traditional
medicines will no doubt continue. Hence, there is an urgent
need to distinguish between the efficacious and safe products
and the ineffective and/or unsafe products. In our efforts to
distinguish between ineffective and/or unsafe products, in vitro
antiplasmodial and cytotoxicity properties of some medicinal
plants from Kenya were investigated.
2. Materials and methods
2.1. Plant collection
Plant materials were collected from Meru and Mombasa
regions in Kenya. GM Mungai carried out authentication at the
National Museums of Kenya where voucher specimens were
deposited (Table 1).ts reserved.
Table 1










Asclepiadaceae Gymnema sylvestre (Retz) Schult whole
plant
cm139
Canellaceae Warbugia ugandensis Sprague stem
bark
cm092
Compositae Vernonia auriculifera Hiern leaves cm044
Compositae Vernonia lasiopus O. Hoffm root
bark
cm066
Leguminosae Caesalpinia volkensii Harms leaves cm131
Leguminosae Strychnos heningsii Gilg twigs cm063
Melianthaceae Turraea robusta Guerke root
bark
cm036
Rubiaceae Pentas bussei Krause whole
plant
cm140





Simaroubaceae Harrisonia abyssinica Oliv stem
bark
cm134
Umbelliferae Centella asiatica Urban whole
plant
cm138
Verbenaceae Clerodendrum eriophyllum Guerke root
bark
cm089




Bioassay results of water, methanol and dichloromethane extracts
Plant/part K1 strain: IC50's in
μg/ml
NF54 strain: IC50's in
μg/ml
Type of extract Type of extract
Water MeOH CH2Cl2 Water MeOH CH2Cl2
Caesalpinia volkensii 68.7 51.4 25.6 N100 65.1 11.9
Centella asiatica ND 19.9 15.4 ND 26 14.9
Clerodendrum
eriophyllum
82.7 47 2.7 N100 79 5.3
Clerodendrum myricoides 64 48.2 15.8 94.3 51.5 10.9
Gompocarpus semilunatus ND 34.4 ND ND 46.1 ND
Gymnema sylvestre N100 58.4 ND N100 40.8 ND
Harrisonia abyssinica 91.1 52.3 4.4 N100 55.4 5.6
Pentas bussei N100 35.2 ND N100 40.5 ND
Strychnos heningsii 29.6 14.6 35.2 33.7 17.9 33.3
Tarena greveolens N100 40.7 ND N100 52.6 ND
Turraea robusta 91.5 3.5 ND N100 2.4 ND
Vernonia auriculifera 84.5 53.8 32.7 N100 60.8 27.3
Vernonia lasiopus 52.2 31.2 4.7 N100 50.5 4.9
Warbugia ugandensis 31.8 17.8 1.4 64 24.3 2.2
Chloroquine 0.091 0.05 0.061 0.003 0.003 0.004
NB: values are mean of two independent experiments.
ND: not done.
Score definition: N50 μg/ml=not active; 11–50 μg/ml=moderately active;
5–10 μg/ml=active; b5 μg/ml=highly active.
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Air-dried and ground plant materials were extracted
successively using Soxhlet with dichloromethane and methanol
respectively. Water extracts were extracted for 6 h in a waterbath
at 70 °C. Organic extracts were dried using a rotary evaporator
while the water extracts were freeze-dried and stored at 4 °C.
For bioassays test samples and control were dissolved in 100%
DMSO to give stock solutions of 10 mg/ml. They were diluted
with media on the day of experiment to desired starting
concentration with amount of DMSO not exceeding 1%.
2.3. Parasite cultivation
Continuous in vitro cultures of asexual erythrocytic stages of
plasmodium strains {NF54-chloroquine sensitive and K1-CQ/
pyrimethamine resistant} were maintained following a modified
procedure described by Trager and Jensen (1976). Parasite
levels in the culture were maintained between 1–10% at a
hematocrit of 5% in RPMI 1640 culture medium supplemented
with B+ erythrocytes, 0.5% AlbumaxR (GIBCO), 50 mg/L
hypoxanthine (FLUKA), 2.1g/L sodium bicarbonate (FLUKA)
and neomycin (10 ml/L). Incubation was carried out at 37 °C in
an atmosphere of 93% N2, 4% CO2, 3% O2.
2.4. Drug assay
This was done using a modification of the semi automated
micro dilution technique of Desjardins et al. (1979) which
measures the ability of the extracts to inhibit the incorporation
of [3H] hypoxanthine into the malaria parasite. Experimentswere conducted on 96 well microtiter plates at a parasiteamia of
0.3% and 2.5% hematocrit. Initial drug concentration was
100 μg/ml. Two fold serial dilution was carried out to make
seven concentrations the lowest being 1.56 μg/ml. Incubation
was carried out at 37 °C in an atmosphere of 93% N2, 4% CO2,
3% O2. Chloroquine was used as the reference drug. After 48 h
50 μL 3H-hypoxanthine (=0.5 μLCi) solution was added to
each well of the plate. The plates were incubated for another
24 h after which they were removed and frozen.
2.5. Harvesting
Plates were thawed at room temperature for 1.5 h before
harvesting. The plates were then harvested with a Betaplate™ cell
harvester (Wallac, Zurich, Switzerland), which transfers the red
blood cells onto a glass fiber filter and washes with distilled water.
The dried filters were inserted into a plastic foil with 10 ml of
scintillation fluid and counted in a Betaplate™ liquid scintillation
counter (Wallac, Zurich, Switzerland). The results were recorded as
counts per minute (cpm) per well at each drug concentration.
2.6. Data analysis
Data was transferred into a graphic programme (EXCEL) and
expressed as a percentage of the untreated controls. The 50%
inhibitory concentration (IC50) value was evaluated by logistic
regression analysis.
2.7. Cytotoxicity
The assay was done following the method of Page et al.
(1993) and Ahmed et al. (1994) where rat skeletal myoblast L6
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containing 10% fetal calf serum and 1.7 μM L-glutamate.
Samples were added to the cultured L6 cells over a
concentration range of 90 to 0.12 μg/ml. The plates were
incubated for 72 h s at 37 °C/5% CO2, after which 10 μL of
resazurin was added as a viability indicator and incubated for
another 2 h. The plates were read with a fluorescence scanner
using an excitation wavelength of 536 nm and an emission
wavelength of 588 nm (Spectra Max Gemini XS Molecular
Devices). Podophyllotoxin (Polysciences Inc. USA) was used
as a positive reference.
3. Results
The IC50 obtained from two independent experiments
with the different extracts on K1 and NF54 strains are
summarized in Table 2. None of the extracts tested had as
good activity as CQ. The IC50 ranged from 1.4 to N100 μg/
ml. Dichloromethane extracts had the best activities
(IC50 b50 μg/ml) except for Strychnos heningsii whose
methanol extract was the most active. Water extracts were
the least active with IC50 N100 μg/ml. Cytotoxicity
properties of dichloromethane extracts and methanol extract
of Turraea robusta were tested and the results are sum-
marized in Table 3. For the purposes of this study, a prom-
ising antimalarial extract was said to lack toxicity to L6 cells
by displaying an IC50 value greater than 90 μg/ml.
Selectivity index (SI) defined, as the ratio of IC50 L6 cells
to IC50 P. falciparum was also determined. The higher the SI
the more promising an extract is due to its selectivity for
malaria parasites. Warbugia ugandensis that had the best
antiplasmodial properties with an IC50 of 1.4 μg/ml (K1) was
also the most toxic to the L6 cells with an IC50 of 0.34 μg/ml.Table 3
Cytotoxicity results and SI of dichloromethane extracts
Plant/part L6 cells IC50's (μg/ml) K1 IC50's (μg/ml) SI
Caesalpinia volkensii 82.4 25.6 3.2










Gymnema sylvestre ND ND ND
Harrisonia abyssinica 32.8 4.4 7.5
Pentas bussei ND ND ND
Strychnos heningsii N90 35.2 N2.6
Tarena greveolens ND ND ND
⁎Turraea robusta 14.3 3.5 4.1
Vernonia auriculifera 84.8 32.7 2.6
Vernonia lasiopus N90 4.7 N10.7
Warbugia ugandensis 0.34 1.4 0.24
Chloroquine 37 0.061 607
Podophyllotoxin 0.01 ND ND
Values are mean of two independent experiments.
SI=selectivity index.
⁎ Methanol extract.4. Discussion and conclusions
We tested 35 extracts from 14 plants for their antiplasmodial
properties in vitro. Water extracts showed no activity with
IC50 N50 μg/ml in both strains except for S. heningsii, which
had moderate activity. Methanol extracts had moderate activity
except for T. robusta that was highly active with an IC50 of 3.5
and 2.4 μg/ml against K1 and NF54 strains respectively.
Dichloromethane extracts showed the highest activity with IC50
ranging from 35.2 to.4 μg/ml against the two strains except
for S. heningsii which had dichloromethane extract as
the least active. Comparing the IC50 values of 55% (5/9)
dichloromethane extracts tested with those previously obtained
for Artemisia annua (3.9 μg/ml) and Azadirachta indica
(10 μg/ml) it can be said that these extracts have promising
results (Maria do Ceu de et al., 2002). This phenomenon of
high activity on dichloromethane extracts over water and
methanol extracts was also reported by Koch et al. (2005). A
probable explanation could be due to lack of tannins,
polysaccharides and other water-soluble molecules that have
no antiplasmodial properties. It was also noted that sensitiv-
ity of the extracts to both CQ-resistant and CQ-sensitive strains
did not differ significantly. Literature reveals that some
plants tested in this study have also been investigated for
their antiplasmodial activity on other strains of P. falciparum.
Of these are Vernonia auriculifera, Vernonia lasiopus
(Muregi et al., 2003), Centella asiatica (Atindehov et al.,
2004), S. heningsii (Kirira et al., 2006), Caesalpinia volkensii
(Kuria et al., 2001) and Harrisonia abyssinica (Kirira et al., 2006;
Clarkson et al., 2004). The results obtained by these authors agree
with what was obtained in this study. However, these authors did
not determine the cytotoxic levels of these extracts.
The dichloromethane extracts and methanol extract of
T. robusta were tested for their cytotoxicity properties in vitro
using L6, rat skeletal myoblast cells. Podophylotoxin was used
as the reference drug. Most extracts showed low cytotoxicity as
is shown in Table 3 with IC50 value of N20 μg/ml (Zirihi et al.,
2005). Selectivity index was also calculated with V. lasiopus
having the highest selectivity of malaria parasite with an SI N10.
Though W. ugandensis possessed a high antiplasmodial activity
(1.4 μg/ml against K1), it also expressed the highest cytotoxicity
with an IC50 of 0.34 μg/ml and a SI of 0.24. This indicates that
the high antiplasmodial activity noticed is probably due to
cytotoxicity rather than activity against the parasite themselves.
According to our classification, dichloromethane extract of
V. lasiopus exhibited promising antimalarial activity with
relatively minimal cytotoxicity. This plant is commonly used
in traditional medicine in Kenya to manage malaria (Muregi
et al., 2003; Bentje, 1994). At least from ethnomedicinal use
there is some evidence that the plant may be safe in humans. It is
therefore planned to evaluate the activity of V. lasiopus in vivo
using Plasmodium berghei mouse model then followed by
isolation of the active compound(s). It is hoped that a lead
compound may be identified that could be developed further as
antimalarial agent. Meanwhile, the antimalarial activity
reported herein probably explains at least part of the therapeutic
efficacy claimed for these plants in traditional medicine.
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